Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21)
© 2023. The Author(s)..
BACKGROUND: There is a rapid increase in the incidence of inflammatory bowel diseases (IBD) in newly industrialized countries, yet epidemiological data is incomplete. We herein report the methodology adopted to study the incidence of IBD in newly industrialized countries and to evaluate the effect of environmental factors including diet on IBD development.
METHODS: Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) is a population-based cohort of newly diagnosed persons with Crohn's disease and ulcerative colitis in Asia, Africa, and Latin America to be followed prospectively for 12 months. New cases were ascertained from multiple sources and were entered into a secured online system. Cases were confirmed using standard diagnostic criteria. In addition, endoscopy, pathology and pharmacy records from each local site were searched to ensure completeness of case capture. Validated environmental and dietary questionnaires were used to determine exposure in incident cases prior to diagnosis.
RESULTS: Through November 2022, 106 hospitals from 24 regions (16 Asia; 6 Latin America; 2 Africa) have joined the GIVES-21 Consortium. To date, over 290 incident cases have been reported. All patients have demographic data, clinical disease characteristics, and disease course data including healthcare utilization, medication history and environmental and dietary exposures data collected. We have established a comprehensive platform and infrastructure required to examine disease incidence, risk factors and disease course of IBD in the real-world setting.
CONCLUSIONS: The GIVES-21 consortium offers a unique opportunity to investigate the epidemiology of IBD and explores new clinical research questions on the association between environmental and dietary factors and IBD development in newly industrialized countries.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
BMC medical research methodology - 23(2023), 1 vom: 25. Mai, Seite 129 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mak, Joyce W Y [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Diet |
|---|
| Anmerkungen: |
Date Completed 29.05.2023 Date Revised 01.06.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s12874-023-01944-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357336984 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357336984 | ||
| 003 | DE-627 | ||
| 005 | 20231226072355.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12874-023-01944-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1191.xml |
| 035 | |a (DE-627)NLM357336984 | ||
| 035 | |a (NLM)37231405 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mak, Joyce W Y |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21) |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.05.2023 | ||
| 500 | |a Date Revised 01.06.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a BACKGROUND: There is a rapid increase in the incidence of inflammatory bowel diseases (IBD) in newly industrialized countries, yet epidemiological data is incomplete. We herein report the methodology adopted to study the incidence of IBD in newly industrialized countries and to evaluate the effect of environmental factors including diet on IBD development | ||
| 520 | |a METHODS: Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) is a population-based cohort of newly diagnosed persons with Crohn's disease and ulcerative colitis in Asia, Africa, and Latin America to be followed prospectively for 12 months. New cases were ascertained from multiple sources and were entered into a secured online system. Cases were confirmed using standard diagnostic criteria. In addition, endoscopy, pathology and pharmacy records from each local site were searched to ensure completeness of case capture. Validated environmental and dietary questionnaires were used to determine exposure in incident cases prior to diagnosis | ||
| 520 | |a RESULTS: Through November 2022, 106 hospitals from 24 regions (16 Asia; 6 Latin America; 2 Africa) have joined the GIVES-21 Consortium. To date, over 290 incident cases have been reported. All patients have demographic data, clinical disease characteristics, and disease course data including healthcare utilization, medication history and environmental and dietary exposures data collected. We have established a comprehensive platform and infrastructure required to examine disease incidence, risk factors and disease course of IBD in the real-world setting | ||
| 520 | |a CONCLUSIONS: The GIVES-21 consortium offers a unique opportunity to investigate the epidemiology of IBD and explores new clinical research questions on the association between environmental and dietary factors and IBD development in newly industrialized countries | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Diet | |
| 650 | 4 | |a Environmental | |
| 650 | 4 | |a Incidence | |
| 650 | 4 | |a Prevalence | |
| 700 | 1 | |a Sun, Yang |e verfasserin |4 aut | |
| 700 | 1 | |a Limsrivilai, Julajak |e verfasserin |4 aut | |
| 700 | 1 | |a Abdullah, Murdani |e verfasserin |4 aut | |
| 700 | 1 | |a Kaibullayeva, Jamilya |e verfasserin |4 aut | |
| 700 | 1 | |a Balderramo, Domingo |e verfasserin |4 aut | |
| 700 | 1 | |a Vergara, Beatriz Iade |e verfasserin |4 aut | |
| 700 | 1 | |a Paudel, Mukesh Sharma |e verfasserin |4 aut | |
| 700 | 1 | |a Banerjee, Rupa |e verfasserin |4 aut | |
| 700 | 1 | |a Hilmi, Ida |e verfasserin |4 aut | |
| 700 | 1 | |a Ali, Raja Affendi Raja |e verfasserin |4 aut | |
| 700 | 1 | |a Wei, Shu Chen |e verfasserin |4 aut | |
| 700 | 1 | |a Ng, Ka Kei |e verfasserin |4 aut | |
| 700 | 1 | |a Altuwaijri, Mansour |e verfasserin |4 aut | |
| 700 | 1 | |a Kelly, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Yamamoto-Furusho, Jesus K |e verfasserin |4 aut | |
| 700 | 1 | |a Kotze, Paulo Gustavo |e verfasserin |4 aut | |
| 700 | 1 | |a Ahuja, Vineet |e verfasserin |4 aut | |
| 700 | 1 | |a Chong, Vui Heng |e verfasserin |4 aut | |
| 700 | 1 | |a Dao, Hang Viet |e verfasserin |4 aut | |
| 700 | 1 | |a Abbey, Yvonne |e verfasserin |4 aut | |
| 700 | 1 | |a Ching, Jessica Y L |e verfasserin |4 aut | |
| 700 | 1 | |a Ho, Agnes |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, Alicia K W |e verfasserin |4 aut | |
| 700 | 1 | |a Bernstein, Charles N |e verfasserin |4 aut | |
| 700 | 1 | |a Gearry, Richard B |e verfasserin |4 aut | |
| 700 | 1 | |a Abreu, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Rubin, David T |e verfasserin |4 aut | |
| 700 | 1 | |a Dotan, Iris |e verfasserin |4 aut | |
| 700 | 1 | |a Hracs, Lindsay |e verfasserin |4 aut | |
| 700 | 1 | |a Kaplan, Gilaad G |e verfasserin |4 aut | |
| 700 | 1 | |a Ng, Siew C |e verfasserin |4 aut | |
| 700 | 0 | |a GIVES-21 Consortium |e verfasserin |4 aut | |
| 700 | 1 | |a Tao, Yan |e investigator |4 oth | |
| 700 | 1 | |a Rong, Jiamei |e investigator |4 oth | |
| 700 | 1 | |a Chen, Xiaocui |e investigator |4 oth | |
| 700 | 1 | |a Song, Huixian |e investigator |4 oth | |
| 700 | 1 | |a Zhou, Chan |e investigator |4 oth | |
| 700 | 1 | |a Mu, Yanju |e investigator |4 oth | |
| 700 | 1 | |a Wei, Wenjuan |e investigator |4 oth | |
| 700 | 1 | |a Bai, Xinyu |e investigator |4 oth | |
| 700 | 1 | |a Aniwan, Satimai |e investigator |4 oth | |
| 700 | 1 | |a Kitiyakara, Taya |e investigator |4 oth | |
| 700 | 1 | |a Harinwan, Kamin |e investigator |4 oth | |
| 700 | 1 | |a Bunchorntavakul, Chalermrat |e investigator |4 oth | |
| 700 | 1 | |a Techathuvanan, Karjpong |e investigator |4 oth | |
| 700 | 1 | |a Kijdamrongthum, Phuripong |e investigator |4 oth | |
| 700 | 1 | |a Suttichaimongkol, Tanita |e investigator |4 oth | |
| 700 | 1 | |a Wetwittayakhlang, Panu |e investigator |4 oth | |
| 700 | 1 | |a Simadibrata, Marcellus |e investigator |4 oth | |
| 700 | 1 | |a Syam, Ari Fahrial |e investigator |4 oth | |
| 700 | 1 | |a Larasati, Deka |e investigator |4 oth | |
| 700 | 1 | |a Tedjasaputra, Tjahjadi Robert |e investigator |4 oth | |
| 700 | 1 | |a Saragih, Arlyando Hezron |e investigator |4 oth | |
| 700 | 1 | |a Koncoro, Hendra |e investigator |4 oth | |
| 700 | 1 | |a Kanabayeva, Aizhan |e investigator |4 oth | |
| 700 | 1 | |a Kongyrbayeva, Nazira |e investigator |4 oth | |
| 700 | 1 | |a Kurmangaliyeva, Assem |e investigator |4 oth | |
| 700 | 1 | |a Laryushina, Yelena |e investigator |4 oth | |
| 700 | 1 | |a Perizat, Toktarova |e investigator |4 oth | |
| 700 | 1 | |a Venera, Ayupova |e investigator |4 oth | |
| 700 | 1 | |a Aidana, Kaliyakparova |e investigator |4 oth | |
| 700 | 1 | |a Toscani, Ignacio |e investigator |4 oth | |
| 700 | 1 | |a Nicoloff, Luciana |e investigator |4 oth | |
| 700 | 1 | |a Howe, Marie |e investigator |4 oth | |
| 700 | 1 | |a Khoo, Xin Hui |e investigator |4 oth | |
| 700 | 1 | |a Heng, Wong Choon |e investigator |4 oth | |
| 700 | 1 | |a Singh, Harjinder |e investigator |4 oth | |
| 700 | 1 | |a Chua, Andrew |e investigator |4 oth | |
| 700 | 1 | |a Hong, Khong Wai |e investigator |4 oth | |
| 700 | 1 | |a Weng, Meng-Tzu |e investigator |4 oth | |
| 700 | 1 | |a Lin, Wei-Chen |e investigator |4 oth | |
| 700 | 1 | |a Lee, Hsi-Chang |e investigator |4 oth | |
| 700 | 1 | |a Chang, Chun-Chao |e investigator |4 oth | |
| 700 | 1 | |a Lin, Chun-Chi |e investigator |4 oth | |
| 700 | 1 | |a Le, Puo Hsien |e investigator |4 oth | |
| 700 | 1 | |a Huang, Tien-Yu |e investigator |4 oth | |
| 700 | 1 | |a Sun, Cheuk-Kay |e investigator |4 oth | |
| 700 | 1 | |a Yeh, Hsing-Jung |e investigator |4 oth | |
| 700 | 1 | |a Ho, Yu Hon |e investigator |4 oth | |
| 700 | 1 | |a AlIbrahim, Bashaar |e investigator |4 oth | |
| 700 | 1 | |a Alahmari, Mohammed |e investigator |4 oth | |
| 700 | 1 | |a Hodges, Phoebe |e investigator |4 oth | |
| 700 | 1 | |a Nsokolo, Bright |e investigator |4 oth | |
| 700 | 1 | |a Awuku, Yaw |e investigator |4 oth | |
| 700 | 1 | |a Li, Michael |e investigator |4 oth | |
| 700 | 1 | |a Chan, Kam Hon |e investigator |4 oth | |
| 700 | 1 | |a Man, Yip Wai |e investigator |4 oth | |
| 700 | 1 | |a Yun-Sze, Thomas Wong |e investigator |4 oth | |
| 700 | 1 | |a Fong, Alex |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t BMC medical research methodology |d 2001 |g 23(2023), 1 vom: 25. Mai, Seite 129 |w (DE-627)NLM111431921 |x 1471-2288 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2023 |g number:1 |g day:25 |g month:05 |g pages:129 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12874-023-01944-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2023 |e 1 |b 25 |c 05 |h 129 | ||